NEJM Interview: Erin Fuse Brown on telehealth arrangements that have prompted concerns about inappropriate prescribing and unnecessary spending.
NEJM Interviews
00:00
Enhancing Transparency in Telehealth and Pharmaceutical Partnerships
This chapter explores proposed policy changes to improve transparency in telehealth partnerships with pharmaceutical companies. It highlights the need for clear guidelines on risky arrangements and emphasizes stricter regulations on financial disclosures and social media marketing of prescription drugs.
Transcript
Play full episode
